MaRS Innovation and Evotec AG today announced the launch of “LAB150”. This transformational Toronto-based partnership will give Canada access to the world-class infrastructure and drug discovery expertise of Evotec, and pair it with cutting-edge drug discovery projects emerging from the 15 Member institutions of MaRS Innovation.
Lab150 is a joint effort by MaRS Innovation and Evotec AG selection and acceleration of early-stage drug discovery projects originating from leading academic institutions and teaching hospitals in Toronto (Canada)
Seed funding for novel, high-risk, high-reward translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging. Funding up to $200,000 over up to 18 months
Letter of Intent Deadline: December 4, 2017 at 2pm EST
Program Information Session: October 10, 2017 at 1pm EDT (Register here)
Synaptive Medical Inc.’s brain simulator training kit, which simulates the features of a living brain to allow users to practice procedures such as stitching a blood vessel, has received an honorable mention in the health category of Fast Company’s 2017 Innovation by Design Awards.